http://www.biospace.comBioSpace RSS GeneratorSat, 25 May 2013 00:53:35 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.biospace.com/news_story.aspx?StoryID=297883&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>RICHMOND, Calif.</span>, <span class"xn-chron">May 24, 2013</span> /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted...Fri, 24 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297850&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>INDIANAPOLIS -- The Patient-Centered Outcomes Research Institute has approved a three-year research award of more than $2 million to the Indiana University Center for Health Services and Outcomes Research and...Thu, 23 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=297851&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>ALACHUA, FL May 23, 2013 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction...Thu, 23 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130522005143&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>ST. LOUIS--(BUSINESS WIRE)--Partek Incorporated is pleased to announce that in collaboration with the Kennedy Krieger Institute it has been awarded $1.8M by the National Institutes of Health (NIH) to develop...Wed, 22 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005879&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BOSTON--(BUSINESS WIRE)--Today the Biogen Idec Foundation announced a $250,000 grant to East End House to develop, implement and evaluate an interactive out-of-school-time (OST) genetics program for middle school...Fri, 17 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130516005762&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>PHILADELPHIA--(BUSINESS WIRE)--The National Disease Research Interchange (NDRI) has been awarded $5,955,435 by the National Institutes of Health (NIH) for the next phase of human tissue collection for the Genotype...Thu, 16 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296588&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br><div class"xn-content"><p><span class"xn-location">BETHESDA, Md.</span>, <span class"xn-chron">May 13, 2013</span> /PRNewswire-USNewswire/ -- Today, the American Gastroenterological Association announced...Tue, 14 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130513005575&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>ALAMEDA, Calif. & JERUSALEM--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences) today announced that Cell Cure Neurosciences has been awarded...Mon, 13 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296432&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Freiburg, Germany & Nijmegen, the Netherlands 13 May 2013. ProQinase and Mercachem received a 2.5 Mio grant from the EUs Eurostars program to support their joint efforts in establishing and expanding an...Mon, 13 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=296105&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>BLACKSBURG, Va.--(BUSINESS WIRE)--Techulon, Inc. announced today that it has been selected by the Defense Advanced Research Projects Agency (DARPA) for a Phase II contract to advance its therapeutic program...Thu, 09 May 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130507006858&newsLang=enStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>CAMBRIDGE, Mass.--(BUSINESS WIRE)--Firefly BioWorks announced today the awarding of three Firefly Frontiers Grants to leading researchers engaged in pushing the boundaries of microRNA research. The Frontiers...Wed, 08 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295636&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>COLUMBIA, Md., May 7, 2013 A&G Pharmaceutical Inc., is pleased to announce that the Avon Foundation of Women has recognized the potential impact of the GP88 blood test for use in the fight against breast cancer...Tue, 07 May 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130503by Richard Daverman, PhD</p><p>May 3, 2013 -- Li Ka-Shing, the richest man in Asia, has given $31 million to Oxford University in England to fund a new drug discovery and healthcare delivery institute. Mr. Li founded the Hutchison Whampoa conglomerate, which is the corporate parent of Hutchison Chi-Med, one of Chinas leading innovative pharmas. Great Britain is matching his gift with another ...Mon, 06 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293536&full=1 <div class"xn-content"><p><span class"xn-location">TARRYTOWN, N.Y.</span> and <span class"xn-location">TUCSON, Ariz.</span>, <span class"xn-chron">April 17, 2013</span> /PRNewswire/ -- ARMGO Pharma and the Muscular Dystrophy Association (<a href"http://www.mda.org/" target"_blank">MDA</a>) today announced that <span class"xn-money">$1 Million</span> has been awarded for preclinical work in...Wed, 17 Apr 2013 12:00:00 AM GMThttp://www.globenewswire.com/news-release/2013/04/17/539059/10028817/en/Xeris-Pharmaceuticals-Awarded-Phase-II-Funding-of-NIH-Fast-Track-SBIR-Grant-to-Advance-Glucagon-for-the-Artificial-Pancreas.htmlAustin, TX, April 17, 2013 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris"), an Austin-based, pharmaceutical company developing patient-friendly injectable treatments for diabetes and other diseases, has been awarded the Phase II installment of a Small Business Innovation Research (SBIR) Fast Track grant for $713,733. The grant, totaling $1.05 million, was awarded in 2012 to advance the company...Wed, 17 Apr 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130416006780&newsLang=enCAMBRIDGE, Mass.--(BUSINESS WIRE)--Firefly BioWorks announced today the awarding of $120,000 in twelve research grants to scientists working to expand the frontiers of microRNA research. The Firefly Frontiers Grant is designed for scientists looking to profile large numbers of samples over multiple microRNA targets. The company received many strong applications from leading academic institutions across...Wed, 17 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293414&full=1<div class"xn-content"><p><span class"xn-location">COLLEGE PARK, Md.</span>, <span class"xn-chron">April 16, 2013</span> /PRNewswire-USNewswire/ -- <a href"http://remediumtechnologies.com/" target"_blank">Remedium Technologies Inc.</a>, a medical device company developing innovative products to control severe hemorrhaging, was awarded a <span class"xn-money">$500,000</span> Small Business Innovation...Tue, 16 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=293087&full=1February20,2013,NewHaven,CT-SvantePbo,PhD,directoroftheDepartmentofGeneticsattheMaxPlanckInstituteforEvolutionaryAnthropologyinLeipzig,Germany,istherecipientofthe2013GeneticsPrizeofTheGruberFoundation.Pboisbeinghonoredwiththisprestigiousinternationalawardforhispioneeringresearchinthefieldofevolutionarygenetics.Heisconsideredthe...Thu, 11 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292954&full=1<div class"xn-content"><p><span class"xn-location">BLUE BELL, Pa.</span>, <span class"xn-chron">April 10, 2013</span> /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has been selected to receive a <span class"xn-money">$3.5 million</span> grant from the National Institute of Allergy and Infectious Diseases (NIAID) to advance the development of its next generation DNA vaccine delivery...Wed, 10 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292805&full=1<div class"xn-content"><p><span class"xn-location">NEW HAVEN, Conn.</span>, <span class"xn-chron">April 9, 2013</span> /PRNewswire/ -- Prometheus Research, an integrated data management services provider, announced today that it has been awarded <span class"xn-money">$700,000</span> by the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to extend its Open Source...Tue, 09 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292721&full=1BOSTON April 8, 2013 Lieutenant Governor Timothy Murray and the Massachusetts Life Sciences Center (MLSC) today announced more than $9.35 million in grants to support life-sciences-related capital projects in the Greater Boston area, including $4 million for Boston Childrens Hospital and $5 million for Harvard Medical School to fund major lab renovation projects. The MLSC has also announced grants...Mon, 08 Apr 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130404005347&newsLang=enCRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation announced today that it has been awarded a grant by the National Institute of Allergy and Infectious Diseases (NIAID) to fund the development of a recombinant vaccine for the prevention of dengue, a disease that kills an estimated 25,000 people annually. VaxInnate is a biotechnology firm pioneering breakthrough technology for developing novel vaccines...Thu, 04 Apr 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130404005231&newsLang=enRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Expression Analysis (EA), a Quintiles company today announced a grant program that provides scientists with leading-edge products and services to advance genomics research. In the fifth year of EAs grant program, EA and Illumina will award two grant winners fully-funded exome and RNA sequencing services along with array-based methylation analysis as part...Thu, 04 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292159&full=1<div class"xn-content"><p><span class"xn-location">NEW CANAAN, Conn.</span>, <span class"xn-chron">April 2, 2013</span> /PRNewswire/ -- The Mikey Czech Foundation, Inc. (the "Foundation", <a href"http://www.mikeyczech.org/" target"_blank">www.mikeyczech.org</a>) a 501 (c)(3) non-profit foundation established by the <span class"xn-person">Stephen J. Czech</span> family to finance medical research...Tue, 02 Apr 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130401005028&newsLang=enCAMBRIDGE, Mass.--(BUSINESS WIRE)--Tetragenetics announced today that it has received Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges. Dr. Ted Clark will continue to pursue an innovative global health research project, titled...Mon, 01 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292060&full=1HAVERHILL, Mass. April 1, 2013 The Massachusetts Life Sciences Center (MLSC) today announced $1.3 million in grants for life-sciences-related capital projects in Northeastern Massachusetts. This total includes $1.24 million for Northern Essex Community College (NECC) to renovate its laboratory space to accommodate the rapidly growing enrollment of students in laboratory sciences, and a $50,00...Mon, 01 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291937&full=1 <div class"xn-content"><p><span class"xn-location">NEW BRUNSWICK, N.J.</span>, <span class"xn-chron">March 28, 2013</span> /PRNewswire-USNewswire/ -- Actinobac Biomed Inc, originally funded with an investment from Foundation Venture Capital Group, Inc., has received a <span class"xn-money">$202,000</span> Small Business Technology Transfer Grant (STTR) from the National Institutes of Health* to...Fri, 29 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291806&full=1<div class"xn-content"><p><i><b>-second generation vaccine expected to be safer to make, with higher yields-</b></i></p><p align"justify"><span class"xn-location">BELLEVILLE, ON</span>, <span class"xn-chron">March 27, 2013</span> /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it...Thu, 28 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291856&full=1NEW YORK, March 28, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced that it has been awarded the second year of a two year grant totaling $595,252 for the "Development of Human, Autologous, Pluripotent Very Small Embryonic Like (VSELs) Stem Cells as a Countermeasure to Radiation Threat", Grant Number...Thu, 28 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291723&full=1<div id"releaseBody"><p>WASHINGTON, DC--(Marketwire - March 27, 2013) - <table class"releaseLink"><tr><td class"releaseLink"><b>Highlighted Links</b></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid1001307&attachid2268136">REGENX BioSciences</a></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid1001307&attachid2268135">EU Research...Wed, 27 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291512&full=1PUTNAM, CT USA (March 25, 2013) Foster Delivery Science, a leading pharmaceutical contract research and manufacturing provider in the field of hot melt extrusion, has been awarded a Manufacturers Technical Assistance Program (MTAP) grant from the University of Connecticut for development of novel processes to improve manufacturability and absorption of poorly water soluble drugs in the body...Mon, 25 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291263&full=1<div class"xn-content"><p><span class"xn-location">MADISON, Wis.</span>, <span class"xn-chron">March 21, 2013</span> /PRNewswire/ -- Cellular Dynamics International (CDI) and Coriell Institute for Medical Research today announced receiving two multi-million dollar grant awards from the California Institute for Regenerative Medicine (CIRM). </p><p>CIRM awarded CDI <span class"xn-money">$16 million...Thu, 21 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291099&full=1<div id"releaseBody"><p>SYDNEY, AUSTRALIA--(Marketwire - March 19, 2013) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: <a href"http://www.marketwire.com/mw/stock.jsp?TickerPBMD">PBMD</a>) (ISIN: US74154B2034) ("Prima", "the Company") is pleased to announce that the Saxony Development Bank in Dresden, Germany (the S&#228;chsische Aufbaubank or "SAB") has approved a EUR 3.8 million (AUD 4.7 million...Wed, 20 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=290865&full=1CAMBRIDGE, Mass. March 18, 2013 The Massachusetts Life Sciences Center (MLSC) today announced a $4.1 million capital grant to the Forsyth Institute for a newly-created Forsyth Center for Salivary Diagnostics (FCSD). The grant will support the construction and equipping of the FCSD, a facility that will seek to revolutionize the way disease testing is performed. In addition, the MLSC announced in...Mon, 18 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=290870&full=1Cambridge, UK, March 18, 2013: Abcam Plc, producer and distributor of high quality protein research tools, today announced its support for local good causes by donating an additional 45,000 to three local charities (15,000 each). The three charities are: Red Balloon, a charity to support the recovery of bullied children; Winter Comfort, a social initiative to help the homeless; and Cambridge Community...Mon, 18 Mar 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130313005101&newsLang=enPRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb has awarded grants totaling $175,000 to the American Cancer Society Eastern Division and Princeton HealthCare System (PHCS) to support comprehensive navigation services for patients with cancer both independently and as part of a collaborative effort among several hospitals in central New Jersey. Several studies have linked patient navigation to...Wed, 13 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=290448&full=1<div class"xn-content"><p><span class"xn-location">BETHESDA, Md.</span>, <span class"xn-chron">March 13, 2013</span> /PRNewswire-USNewswire/ -- The American Gastroenterological Association (AGA) Research Foundation is pleased to welcome Salix Pharmaceuticals as a supporter of the foundation's endowment.</p><p>The AGA Research Foundation provides research funding grants to young investigators in...Wed, 13 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=290252&full=1 CAMBRIDGE, England, March 12, 2013 -- /PRNewswire/ --</p><p>ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately 0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax, which...Tue, 12 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=289987&full=111 March 2013: A consortium comprising vaccine developer Prokarium Ltd and the University of Birminghams Institute of Microbiology and Infection has received an award for advancing the industrial application of synthetic biology. The 0.4m grant from the Technology Strategy Board (TSB), the UKs innovation agency, and the Biotechnology and Biological Sciences Research Council (BBSRC) has been earmarked...Mon, 11 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=289846&full=1NEW YORK (March 7, 2013) -- Weill Cornell Medical College has been awarded more than $1.9 million by the National Institute of Mental Health of the National Institutes of Health to lead an innovative research study using advanced neuroimaging and clinical evaluations of patients with chronic fatigue syndrome (CFS). The new four-year clinical study, to be conducted in collaboration with Icahn School...Thu, 07 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=289173&full=1 <div class"xn-content"><p><span class"xn-location">WHITE PLAINS, N.Y.</span>, <span class"xn-chron">Feb. 28, 2013</span> /PRNewswire/ -- Medical innovation and sustained research investment are dramatically transforming the landscape in blood cancers. To that end, The Leukemia &amp; Lymphoma Society (LLS) continues to drive a progressive research agenda to improve outcomes for patients who urgently...Fri, 01 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=289209&full=1 <div class"xn-content"><p><span class"xn-location">SAN DIEGO</span>, <span class"xn-chron">March 1, 2013</span> /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink, trilinkbiotech.com) was recently awarded a Phase I SBIR Grant of approximately <span class"xn-money">$130,000</span> by the National Institutes of Health to develop an approach to RNA sample preparation for Next Generation Sequencing...Fri, 01 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=289085&full=1SAN DIEGO (February 28, 2013) - TriLink BioTechnologies Inc. (TriLink, trilinkbiotech.com) was recently awarded a Phase I SBIR Grant of approximately $130,000 by the National Institutes of Health to develop an approach to RNA sample preparation for Next Generation Sequencing (NGS) using TriLink's expertise in nucleic acid chemistry. This is the sixth Phase I grant TriLink has been awarded and it will...Thu, 28 Feb 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=288566&full=1February 26, 2013 (CLEVELAND, OHIO) Clinical stage biotechnology startup Milo Biotechnology has received a $300,000 Phase I SBIR grant from NIHs National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The grant, which was awarded under NIAMS new Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases program, will enable Milo Biotechnology to...Mon, 25 Feb 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=287408&full=1<div class"xn-content"><p><span class"xn-location">CHAPEL HILL, N.C.</span>, <span class"xn-chron">Feb. 12, 2013</span> /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that the National Institute of Allergy and Infectious...Tue, 12 Feb 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130212005595&newsLang=enFORT COLLINS, Colo.--(BUSINESS WIRE)--The National Institutes of Health has awarded a Small Business Innovation Research (SBIR) grant to Ventria Bioscience and the University of Southern California (USC), with the goal of developing a cost-effective method for producing clinical-grade proinsulin-transferrin (ProINS-Tf) using Ventria Biosciences ExpressTec recombinant expression system. ProINS-Tf is...Tue, 12 Feb 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130212005376&newsLang=enCAMBRIDGE, Mass.--(BUSINESS WIRE)--Firefly BioWorks announces today the creation of the Firefly Frontiers Grant, open to any scientist or engineer from an academic or non-profit research institution. We are excited to provide financial support to researchers for expanding the horizons of microRNA research. We encourage applicants to explore high-impact questions and those high-risk explorations that...Tue, 12 Feb 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=287069&full=1<div class"xn-content"><p><span class"xn-location">KALAMAZOO, Mich.</span>, <span class"xn-chron">Feb. 7, 2013</span> /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) announced today that it has received an award from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to conduct preclinical research on a first-in-class mTOT Modulator, MSDC-0160, as a potential treatment...Thu, 07 Feb 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=287099&full=1WALTHAM, Mass. -- The Massachusetts Life Sciences Center (MLSC) Board of Directors has awarded a $5 million capital grant to support the establishment of LabCentral, comprising state-of-the-art facilities and services for emerging life sciences companies planned for Cambridges Kendall Square. LabCentral will use the grant funding to build a life sciences laboratory to facilitate the creation of startup...Thu, 07 Feb 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130205005195&newsLang=enWALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat a wide range of debilitating diseases, announced today that it has been awarded a grant from the Cystic Fibrosis Foundation to demonstrate that Kalas Mucosal-Penetrating Products (MPPs) also penetrate bacterial biofilms. Bacteria...Tue, 05 Feb 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=286577&full=1 <div class"xn-content"><p><span class"xn-location">LOS ANGELES</span>, <span class"xn-chron">Feb. 4, 2013</span> /PRNewswire/ -- NeuroSigma, Inc., a <span class"xn-location">California</span>-based medical device company, today announced it received a Notice of Award, for a Fast Track Small Business Innovation Research (SBIR) grant, from the National Institute of Neurological Disorders and Stroke...Mon, 04 Feb 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=286628&full=1Munich, Germany, February 4, 2013 / B3C newswire / As of January 2013 apceth has entered the second round of funding for the development of its first cancer therapeutic based on patients own modified adult mesenchymal stem cells (MSC) running under the portfolio name Agenmestencel-T.</p><p>In December 2012 apceth has successfully concluded the first 2.5-year round of funding through the Federal...Mon, 04 Feb 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=286435&full=1<div class"xn-content"><p><span class"xn-location">NEW YORK</span>, <span class"xn-chron">Jan. 31, 2013</span> /PRNewswire/ -- The <a href"http://www.lupusresearchinstitute.org/" target"_blank">Lupus Research Institute (LRI)</a> - world's leading supporter of innovative research in lupus -- today awards <span class"xn-money">$3.6 million</span> in <a href"http://www.lupusresearchinstitute.org...Fri, 01 Feb 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130201005219&newsLang=enSTOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex (STO:ALNX) announces that Allenex group company AbSorber, together with EUROSTAM, a consortium of European Transplant Centers, has been supported by a 2.6 million grant as part of the European Commission 7th framework programme (FP7). This is part of an ongoing Europe-wide strategy to enhance transplantation of highly sensitized patients where...Fri, 01 Feb 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=286181&full=1<div class"xn-content"><p><b><i>Additional <span class"xn-money">One Million Dollars</span> in Funding Expands the Scope of Neurological Research</i></b></p><p><span class"xn-location">WINSTON-SALEM, N.C.</span>, <span class"xn-chron">Jan. 30, 2013</span> /PRNewswire-USNewswire/ -- With the infusion of an additional<b></b><span class"xn-money">$1 million</span> of financial support from<b></b...Wed, 30 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=286126&full=1<div id"releaseBody"><p>MECHELEN, BELGIUM--(Marketwire - January 30, 2013) - Galapagos NV (Euronext: GLPG) announcedtoday that it has been awarded a EUR2.5 million grant from the Flemishagency forInnovation by Science and Technology (IWT) for inflammatory bowel disease(IBD)research and development. The goal of this 2.5-year project is toidentify newtherapeutic compounds for...Wed, 30 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=285889&full=1<div class"xn-content"><p><span class"xn-location">JERUSALEM</span>, <span class"xn-chron">Jan. 28, 2013</span> /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) and its portfolio companies ProtAb Ltd. ("ProtAb") and KAHR Medical Ltd. ("KAHR")<b></b>announced today that they will receive additional funding of <span class"xn-money">NIS 10.7 million</span> (over <span class"xn...Mon, 28 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=285533&full=1 <div class"xn-content"><p><span class"xn-location">SEATTLE</span>, <span class"xn-chron">Jan. 23, 2013</span> /PRNewswire/ -- Invictus Foundation, a national nonprofit organization offering one on one and family behavioral health counseling services with licensed behavioral health providers to active duty military, National Guard, Reserve forces, veterans of <span class"xn-location">Iraq</span...Wed, 23 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130117005068&newsLang=enINGELHEIM, Germany--(BUSINESS WIRE)--The Boehringer Ingelheim and EFSD diabetes partnership has opened submissions for diabetes research grant applications from across Europe. In a collaboration which aims to stimulate and accelerate European research in diabetes, the EFSD/Boehringer Ingelheim European Diabetes Research Programmes have dedicated more than 2.5 million euros over three years to support...Thu, 17 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130115006823&newsLang=enSAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced two new grant recipients of its Agricultural Greater Good Initiative at the 21st International Plant and Animal Genome Conference. The recipients, International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) and Biosciences Eastern and Central Africa International Livestock Research Institute Hub (BecA-ILRI Hub...Wed, 16 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130115005175&newsLang=enMENLO PARK, Calif.--(BUSINESS WIRE)--Calysta Energy (www.calystaenergy.com) today announced it has been awarded a Small Business Innovation Research (SBIR) Phase 1 grant from the National Science Foundation. The grant supports development of a production platform for a new class of modified lipids (fats) with applications in a range of industrial products including plastics, detergents, and cosmetics...Tue, 15 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130114006407&newsLang=enBAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies (Euronext: DBV ISIN: FR0010417345) (Paris:DBV), creator of Viaskin, a new standard in the treatment of allergies, announced today that the Company and the French Institute for Agricultural Research-INRA (Molecular Virology and Immunology Unit, VIM-U892) have been awarded a research grant of nearly 600.000 from the French National...Tue, 15 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130111005539&newsLang=enLANSING, Mich.--(BUSINESS WIRE)--On January 3, the U.S. Department of Energy announced that it has awarded Novozymes and MBI up to $2.5 million to develop new enzyme-based technologies to convert corn stover into sugars for subsequent conversion into biofuels.Fri, 11 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=284460&full=1<div id"releaseBody"><p>MECHELEN, BELGIUM--(Marketwire - January 10, 2013) - Galapagos NV (Euronext: GLPG) announcedtoday that is has been awarded a EUR2.7 million grant from the Flemishagency forInnovation by Science and Technology (IWT) to discover newantibiotictreatments.<p>A number of bacteria have become resistant to existing antibiotics,posing apressing...Thu, 10 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130108006447&newsLang=enFARGO, N.D. & SUNNYVALE, Calif.--(BUSINESS WIRE)--Altravax, Inc. announced today that it has been awarded two Advanced Technology Small Business Innovation Research grants from the NIHs National Institute of Allergy and Infectious Diseases for research on vaccines to prevent infection by dengue virus and to treat chronic hepatitis B. Each of these viruses is a global problem and the focus of Altravax...Tue, 08 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130107005389&newsLang=enBURLINGAME, Calif.--(BUSINESS WIRE)--Reset Therapeutics, the leader in harnessing the power of the bodys internal clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications, today announced that it has been awarded a five-year cooperative agreement by the National Institutes of Health (NIH) to develop a new drug to treat narcolepsy. Resets award includes...Mon, 07 Jan 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20130107005985&newsLang=enSAN ANTONIO--(BUSINESS WIRE)--America Stem Cell, Inc. (ASC) today announced that it has been awarded an Advanced Technology Small Business Innovation Research (SBIR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health. This grant will be led by Dr. Leonard Miller, VP Preclinical Research at ASC, in collaboration with Dr. Larry Sherman at the Oregon National Primate...Mon, 07 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=283643&full=1<div class"xn-content"><p /><p><span class"xn-location">SAN CARLOS, Calif.</span>, <span class"xn-chron">Jan. 3, 2013</span> /PRNewswire/ -- Savant HWP, Inc. today announced the receipt of a three-year grant to support the development of 18-MC (18-methoxycoronaridine) as a potential orally active treatment for drug addiction, obesity and other forms of compulsive behavior. The grant, Award Number...Thu, 03 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=283213&full=1<div id"releaseBody"><p>SALT LAKE CITY, UT--(Marketwire - December 27, 2012) - <b>Q Therapeutics, Inc.</b> today announced that its collaborators at The Johns Hopkins University have been awarded $1.3 million in a third year of grant funding from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). Q Therapeutics is an emerging biotechnology...Thu, 27 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282916&full=1<div id"releaseBody"><p>STONY BROOK, NY--(Marketwire - December 20, 2012) - <table class"releaseLink"><tr><td class"releaseLink"><b>Highlighted Links</b></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire.com/mw/mmframe?prid968263&attachid2187387">http://regionalcouncils.ny.gov/assets/documents/2012REDCbooklet.pdf</a></td></tr><tr><td><p>&nbsp;</p><a href"http://www2.marketwire...Thu, 20 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282965&full=1Brisbane, Australia, 20 December 2012 -- Allied Healthcare Group (AHZ) today announced Professor Ian Frazer has been awarded a grant to support the ongoing development of a novel DNA vaccine for the prevention and treatment of human papilloma virus (HPV).</p><p>Professor Frazer, and his team at the University of Queensland, will receive funding from Australias National Health and Medical Research...Thu, 20 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282630&full=1 <div class"xn-content"><p><span class"xn-location">SAN DIEGO</span>, <span class"xn-chron">Dec. 18, 2012</span> /PRNewswire/ -- MabVax Therapeutics Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received a Small Business Innovation...Tue, 18 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282401&full=1PORTLAND, Ore. Oregon Health & Science University Knight Cancer Institutes vision to advance the science behind personalized cancer care has earned the buy-in of one of the nations top private research funders. </p><p>The Los Angeles-based W.M. Keck Foundation has awarded $1 million to a multinational, multi-institutional team developing applications and work flow processes for a revolutionary...Fri, 14 Dec 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20121213006033&newsLang=enSEOUL, South Korea--(BUSINESS WIRE)--The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that YKP10811, for the treatment of chronic idiopathic constipation, has been awarded funding from the Korea Drug Development Fund to support clinical development for the next two years. An agreement between the two parties was signed on December 13. Thu, 13 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282306&full=1NEW YORK, NY, December 10, 2012 /EIN Presswire/ -- FPRT Bio, a privately held clinical stage biopharmaceutical company, has been awarded a Therapeutic Development Initiative grant to study molecule, XPro(R)1595, in Parkinson's disease. The work will be conducted in collaboration with Emory University.</p><p>XPro1595 uses DN-TNF technology to neutralize soluble TNF to prevent chronic inflammation...Thu, 13 Dec 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20121212005933&newsLang=enNEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that Brainstorm Cell Therapeutics Ltd. was awarded a 3 million NIS grant from Israels Office of the Chief Scientist (OCS) for the year 2013. The grant is intended to support BrainStorms Research and...Wed, 12 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282164&full=1Paris, December 12, 2012 - Curie-Cancer, the body responsible for developing Institut Curies industry partnership activities, announces today that it has provided funding for its first five late-stage internal research projects. This funding will enable Curies scientists to gather more evidence and progress with the selected projects, making their research more attractive to industrial companies...Wed, 12 Dec 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20121212005613&newsLang=enAARHUS, Denmark--(BUSINESS WIRE)--Today CLC bio announced the participation in the European FP7 project, STATegra, and receives 1.3 million US Dollars out of the total $7.8M project budget. STATegra aims to develop a user-friendly integral analysis platform for different omics data that is capable of providing a more efficient use of genomics technologies. As a first, this project will generate and...Wed, 12 Dec 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20121211005139&newsLang=enNEW YORK--(BUSINESS WIRE)--Soldiers returning home after serving in Iraq or Afghanistan sometimes find that their greatest battle still lies ahead. Military deployments can trigger mental health problems such as depression, post-traumatic stress and substance abuse. Of nearly 2 million service personnel deployed to Iraq and Afghanistan, as many as 300,000 may be in need of mental health services. Tue, 11 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=281680&full=1Wenham, MAvascuVis was awarded the highly competitive NSF SBIR Phase I funding for development of vascuCAP, to begin January 2013. The Wenham based company seeks to establish feasibility and market potential of vascuCAP, the companys vascular disease computer-aided prognostic software. </p><p>The goal of Phase I research is a software development endpoint. CAP seeks to extend beyond static...Fri, 07 Dec 2012 12:00:00 AM GMT